Rankings
▼
Calendar
INVA FY 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$261M
+20.2% YoY
Gross Profit
$261M
100.0% margin
Operating Income
$238M
91.3% margin
Net Income
$395M
151.4% margin
EPS (Diluted)
$3.48
Cash Flow
Operating Cash Flow
$224M
Free Cash Flow
$224M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$548M
Total Liabilities
$389M
Stockholders' Equity
$154M
Cash & Equivalents
$62M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$261M
$217M
+20.2%
Gross Profit
$261M
$216M
+20.9%
Operating Income
$238M
$184M
+29.8%
Net Income
$395M
$134M
+194.5%
← Q4 2017
All Quarters
Q1 2018 →